Department of Biomedical Engineering, School of Medicine, X-Lab for Transmembrane Signaling Research, Tsinghua University, Beijing, 100084, China.
School of Biological Science and Medical Engineering, Beihang University, Beijing, 100083, China.
Nat Commun. 2018 Apr 17;9(1):1504. doi: 10.1038/s41467-018-03719-6.
GCaMP, one popular type of genetically-encoded Ca indicator, has been associated with various side-effects. Here we unveil the intrinsic problem prevailing over different versions and applications, showing that GCaMP containing CaM (calmodulin) interferes with both gating and signaling of L-type calcium channels (Ca1). GCaMP acts as an impaired apoCaM and Ca/CaM, both critical to Ca1, which disrupts Ca dynamics and gene expression. We then design and implement GCaMP-X, by incorporating an extra apoCaM-binding motif, effectively protecting Ca1-dependent excitation-transcription coupling from perturbations. GCaMP-X resolves the problems of detrimental nuclear accumulation, acute and chronic Ca dysregulation, and aberrant transcription signaling and cell morphogenesis, while still demonstrating excellent Ca-sensing characteristics partly inherited from GCaMP. In summary, CaM/Ca1 gating and signaling mechanisms are elucidated for GCaMP side-effects, while allowing the development of GCaMP-X to appropriately monitor cytosolic, submembrane or nuclear Ca, which is also expected to guide the future design of CaM-based molecular tools.
GCaMP,一种流行的基因编码钙指示剂,与各种副作用有关。在这里,我们揭示了普遍存在于不同版本和应用中的内在问题,表明含有 CaM(钙调蛋白)的 GCaMP 会干扰 L 型钙通道 (Ca1) 的门控和信号转导。GCaMP 作为一种功能失调的 apoCaM 和 Ca/CaM,这两者对 Ca1 都至关重要,会破坏 Ca 动力学和基因表达。然后,我们通过引入额外的 apoCaM 结合基序来设计和实施 GCaMP-X,有效地保护 Ca1 依赖性的兴奋-转录偶联免受干扰。GCaMP-X 解决了有害的核积累、急性和慢性 Ca 失调以及异常转录信号和细胞形态发生的问题,同时仍然展示了部分从 GCaMP 继承而来的优异 Ca 感应特性。总之,阐明了 GCaMP 副作用的 CaM/Ca1 门控和信号转导机制,同时允许开发 GCaMP-X 来适当监测细胞溶质、亚膜或核 Ca,这也有望指导基于 CaM 的分子工具的未来设计。